Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hyperprogressive disease with anti-PD-1 and anti-PD-L1.

× No keyword cloud information.

12 in total

1. Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective Study.

Authors: Hiroki Ishihara; Tsunenori Kondo; Toshio Takagi; Hidekazu Tachibana; Hironori Fukuda; Kazuhiko Yoshida; Junpei Iizuka; Hirohito Kobayashi; Kazunari Tanabe
Journal: Target Oncol Date: 2018-10 Impact factor: 4.493

2. The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance.

Authors: Yang-Chun Feng; Wen-Li Ji; Na Yue; Yan-Chun Huang; Xiu-Min Ma
Journal: Cancer Manag Res Date: 2018-01-18 Impact factor: 3.989

3. PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.

Authors: Bingxin Zheng; Tingting Ren; Yi Huang; Kunkun Sun; Shidong Wang; Xing Bao; Kuisheng Liu; Wei Guo
Journal: J Hematol Oncol Date: 2018-02-06 Impact factor: 17.388

4. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4⁺ and CD8⁺ T Cells in Hepatocellular Carcinoma Patients.

Authors: Jiayu Liu; Jiaqian Li; Min He; Geng-Lin Zhang; Qiyi Zhao
Journal: J Immunol Res Date: 2018-07-18 Impact factor: 4.818

5. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.

Authors: Tingting Ren; Bingxin Zheng; Yi Huang; Shidong Wang; Xing Bao; Kuisheng Liu; Wei Guo
Journal: Cell Death Dis Date: 2019-03-18 Impact factor: 8.469

6. PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity.

Authors: Jianshu Wei; Can Luo; Yao Wang; Yelei Guo; Hanren Dai; Chuan Tong; Dongdong Ti; Zhiqiang Wu; Weidong Han
Journal: J Immunother Cancer Date: 2019-08-07 Impact factor: 13.751

7. Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer.

Authors: Donghai Xiong; Yian Wang; Ming You
Journal: Sci Rep Date: 2019-07-29 Impact factor: 4.379

Review 8. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review.

Authors: Hong-Bo Li; Zi-Han Yang; Qing-Qu Guo
Journal: Cell Commun Signal Date: 2021-11-24 Impact factor: 5.712

9. An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy.

Authors: Hui Wang; Qian Xu; Chanyuan Zhao; Ziqi Zhu; Xiaoqing Zhu; Junjie Zhou; Shuming Zhang; Tiqun Yang; Biying Zhang; Jun Li; Meiling Yan; Renming Liu; Changchun Ma; Yan Quan; Yongqu Zhang; Weifeng Zhang; Yiqun Geng; Chuangzhen Chen; Shaobin Chen; Ditian Liu; Yuping Chen; Dongping Tian; Min Su; Xueling Chen; Jiang Gu
Journal: J Immunother Cancer Date: 2020-08 Impact factor: 13.751

Review 10. Biomarkers for predicting the efficacy of immune checkpoint inhibitors.

Authors: Chengji Wang; He-Nan Wang; Liang Wang
Journal: J Cancer Date: 2022-01-01 Impact factor: 4.207